Braithwaite RS - Search Results

1

Estimating the rate of accumulating drug resistance mutations in the HIV genome.

Braithwaite RS, Shechter S, Chang CC, Schaefer A, Roberts MS. Braithwaite RS, et al. Value Health. 2007 May-Jun;10(3):204-13. doi: 10.1111/j.1524-4733.2007.00170.x. Value Health. 2007. PMID: 17532813 Free article.

2

Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation.

Braithwaite RS, Shechter S, Roberts MS, Schaefer A, Bangsberg DR, Harrigan PR, Justice AC. Braithwaite RS, et al. J Antimicrob Chemother. 2006 Nov;58(5):1036-43. doi: 10.1093/jac/dkl386. Epub 2006 Oct 5. J Antimicrob Chemother. 2006. PMID: 17023498

3

Estimating the impact of alcohol consumption on survival for HIV+ individuals.

Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, Rodriguez MC, Rabeneck L, Bryant K, Justice AC. Braithwaite RS, et al. AIDS Care. 2007 Apr;19(4):459-66. doi: 10.1080/09540120601095734. AIDS Care. 2007. PMID: 17453583 Free PMC article.

4

Estimating the proportion of patients infected with HIV who will die of comorbid diseases.

Braithwaite RS, Justice AC, Chang CC, Fusco JS, Raffanti SR, Wong JB, Roberts MS. Braithwaite RS, et al. Am J Med. 2005 Aug;118(8):890-8. doi: 10.1016/j.amjmed.2004.12.034. Am J Med. 2005. PMID: 16084183

5

Incorporating quality of evidence into decision analytic modeling.

Braithwaite RS, Roberts MS, Justice AC. Braithwaite RS, et al. Ann Intern Med. 2007 Jan 16;146(2):133-41. doi: 10.7326/0003-4819-146-2-200701160-00008. Ann Intern Med. 2007. PMID: 17227937 Free PMC article.

6

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

Braithwaite RS, Kozal MJ, Chang CC, Roberts MS, Fultz SL, Goetz MB, Gibert C, Rodriguez-Barradas M, Mole L, Justice AC. Braithwaite RS, et al. AIDS. 2007 Jul 31;21(12):1579-89. doi: 10.1097/QAD.0b013e3281532b31. AIDS. 2007. PMID: 17630553 Free PMC article.

7

Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model.

Braithwaite RS, Roberts MS, Chang CC, Goetz MB, Gibert CL, Rodriguez-Barradas MC, Shechter S, Schaefer A, Nucifora K, Koppenhaver R, Justice AC. Braithwaite RS, et al. Ann Intern Med. 2008 Feb 5;148(3):178-85. doi: 10.7326/0003-4819-148-3-200802050-00004. Ann Intern Med. 2008. PMID: 18252681 Free PMC article.

8

Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?

Braithwaite RS, Roberts MS, Goetz MB, Gibert CL, Rodriguez-Barradas MC, Nucifora K, Justice AC. Braithwaite RS, et al. Clin Infect Dis. 2009 Mar 15;48(6):822-6. doi: 10.1086/596768. Clin Infect Dis. 2009. PMID: 19210173 Free PMC article.

9

Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?

Braithwaite RS, Fiellin DA, Nucifora K, Bryant K, Roberts M, Kim N, Justice AC. Braithwaite RS, et al. Value Health. 2010 Aug;13(5):535-42. doi: 10.1111/j.1524-4733.2010.00714.x. Epub 2010 Mar 22. Value Health. 2010. PMID: 20345544 Free PMC article.

10

HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights.

Khademi A, Saure D, Schaefer A, Nucifora K, Braithwaite RS, Roberts MS. Khademi A, et al. Among authors: braithwaite rs. Value Health. 2015 Dec;18(8):1113-9. doi: 10.1016/j.jval.2015.10.003. Epub 2015 Nov 12. Value Health. 2015. PMID: 26686798 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters